OHSU Research Drives FDA Approval For Novel Use of Anemia Drug In Brain Cancer Imaging
Candace Chin
The Food and Drug Administration has approved ferumoxytol, known clinically as FERABRIGHT™, as a contrast agent physicians can use to... Read More The post OHSU Research Drives FDA Approval For Novel Use of Anemia Drug In Brain Cancer Imaging appeared first on OHSU-PSU School of Public Health .